Diabetes y enfermedades metabólicas
Pfizer (United States)
Nueva York, Estados UnidosPfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2002
-
Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells
Atherosclerosis, Vol. 160, Núm. 1, pp. 49-58